aTyr Pharma (LIFE) Misses Q2 EPS by 6c

aTyr Pharma (NASDAQ: LIFE) reported Q2 EPS of ($0.44), $0.06 worse than the analyst estimate of ($0.38).

For earnings history and earnings-related data on aTyr Pharma (LIFE) click here.

You May Also Be Interested In

• KB Home (KBH) Tops Q3 EPS by 16c
• MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
• Willdan to buy Mantis Innovation for $285M in cash